LifeVantage Co. (NASDAQ:LFVN) Short Interest Up 13.8% in October

LifeVantage Co. (NASDAQ:LFVN) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 231,100 shares, an increase of 13.8% from the September 30th total of 203,000 shares. Currently, 2.3% of the shares of the stock are sold short. Based on an average daily volume of 94,300 shares, the days-to-cover ratio is currently 2.5 days.

Institutional Trading of LifeVantage

Several institutional investors and hedge funds have recently bought and sold shares of LFVN. Hillsdale Investment Management Inc. purchased a new stake in shares of LifeVantage in the 1st quarter worth about $76,000. Hantz Financial Services Inc. purchased a new stake in LifeVantage during the 2nd quarter valued at about $91,000. Ritholtz Wealth Management increased its holdings in shares of LifeVantage by 62.0% in the 3rd quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock worth $346,000 after purchasing an additional 10,974 shares in the last quarter. Empowered Funds LLC raised its stake in shares of LifeVantage by 8.1% in the first quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock worth $461,000 after purchasing an additional 5,742 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its position in shares of LifeVantage by 2.8% during the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after buying an additional 6,121 shares during the last quarter. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

LifeVantage Stock Performance

NASDAQ:LFVN traded down $0.72 during mid-day trading on Thursday, reaching $12.21. The stock had a trading volume of 17,460 shares, compared to its average volume of 60,110. The stock has a market capitalization of $155.08 million, a P/E ratio of 46.18 and a beta of 0.84. LifeVantage has a one year low of $4.20 and a one year high of $14.71. The firm has a 50 day moving average price of $10.86 and a two-hundred day moving average price of $8.35.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. The business had revenue of $47.21 million during the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%.

LifeVantage Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 1.31%. The ex-dividend date is Monday, December 2nd. LifeVantage’s dividend payout ratio is currently 57.14%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.